Quoin Pharmaceuticals Ltd. business relationships
Companies named in Quoin Pharmaceuticals Ltd.’s 10-K filed 2026-03-26, and public companies whose annual reports name Quoin Pharmaceuticals Ltd.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 4 / 100 Top 12% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Quoin Pharmaceuticals Ltd.’s annual report 6
“We also agreed to pay Skinvisible 25% of any revenues we receive as royalties in the event that we sublicense any licensed products to a third party.” SEC filing
“License Agreement with Skinvisible” SEC filing
“License and Distribution Agreement, dated November 5, 2021, by and between Quoin Pharmaceuticals, Inc. and AFT Pharmaceuticals Ltd.” SEC filing
“Supply Agreement, dated September 15, 2021, by and between Quoin Pharmaceuticals, Inc. and AFT Pharmaceuticals Ltd.” SEC filing
“License and Distribution Agreement, dated July 14, 2022, by and between Quoin Pharmaceuticals, Inc. and Endo Ventures Limited” SEC filing
“Supply Agreement, dated July 14, 2022, by and between Quoin Pharmaceuticals, Inc. and Endo Ventures Limited” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.